comprehensive -WSS

comprehensive

author：entertainment 2025-08-26 10:54:53 - browse：38

How does a drug industry lobbying group move forward after years of upheaval, including having four CEOs in four years?

This week on “The Readout LOUD,” STAT’s Chief Washington Correspondent Rachel Cohrs Zhang joins us to discuss the layoffs at trade group BIO and how things may be changing at the trade group. We also invite STAT reporter Eric Boodman on to talk about his new investigative series of stories exploring how Black women with sickle cell disease were coerced into getting sterilized.

To read the first article in the Coercive Care investigative series and find future installments, go here; For more on the layoffs at BIO, go here; To keep tabs on health policy and BIO’s reorganization, sign up for the D.C. Diagnosis newsletter here; And you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Food makers tried to stack nutrition panel with preferred experts

hotspot

explore

WSS

Patients, digital health players weigh in on FTC's data privacy plan

FDA proposes changes to key medical devices approval pathway

Acelyrin, a rare IPO success, stumbles in its first big test

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Regeneron agrees to White House price limits on anti

Be careful with at

entertainment

comprehensive

focus

Hollywood unions extend contract negotiations for actors

How medical schools plan to diversify without affirmative action

New air purifier tech could be key to improving indoor air quality

Bird flu researchers hone in on Finland’s mink farms

Medical records are filled with copy

Food makers to regulators: Ultra

Peter Hotez and the public health issue of online harassment

Long Covid needs a new name — and a new frame

DIEP, the 'gold standard' of breast reconstruction, is under threat

Regeneron agrees to White House price limits on anti

focus

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

New weight loss drugs vying to be the next Wegovy or Mounjaro

Hospitals are dialing back on venture capital investing

How housing is health care on Long Island

What to make of Biden’s latest efforts on cancer research

Patients, digital health players weigh in on FTC's data privacy plan

focus

hotspot

explore

leisure time